2-Ethylhexanoic Acid

2-Ethylhexanoic Acid

SCHEMBL1349240

CCC.CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.95
MAPK1 P28482 2/20 0.95
CA1 P00915 4/20 0.61
SLC1A2 P43004 3/20 0.59
SLC1A1 P43005 3/20 0.59
SLC1A3 P43003 2/20 0.59
CHRM1 P11229 1/20 0.54
AKR1A1 P14550 1/20 0.54
CHRM3 P20309 1/20 0.54
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
ADRA1A P35348 1/20 0.54
HRH1 P35367 1/20 0.54
DRD3 P35462 1/20 0.54
SLC6A3 Q01959 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC2 Q92769 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
GRIK1 P39086 2/20 0.52
GRIK2 Q13002 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Ethylhexanoic Acid SCHEMBL25318625 1.00 CA2 (0.95) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL8387406 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL25800 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL301319 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL5512393 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL282014 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL5695779 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL8375903 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL6121661 0.98 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL21054917 0.95 CA2 (0.95) CA2MAPK1CA1SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190299032-A1 Oil-In-Water Type Emulsion Cosmetic Composition SHISEIDO COMPANY, LTD. (JP) 2019-10-03 US claimed
US-20180056096-A1 Oil-In-Water Type Emulsion Cosmetic Composition SHISEIDO CO., LTD. (JP) 2018-03-01 US claimed
US-20230404877-A1 POWDER-CONTAINING COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2023-12-21 US disclosed
EP-3383362-B1 SKIN CARE COMPOSITION WILD & NATURAL IBIZA COSMETICS CORP S L (ES) 2023-11-01 EP disclosed
US-20230293417-A1 ADENOSINE-CONTAINING COMPOSITION AND METHOD FOR SUPPRESSING PRECIPITATION OF ADENOSINE SHISEIDO COMPANY, LTD. (JP) 2023-09-21 US disclosed
EP-3666251-B1 POWDER-CONTAINING WATER-BASED COMPOSITION AND EXTERNAL SKIN PREPARATION SHISEIDO CO LTD (JP) 2023-09-06 EP disclosed
EP-4233835-A1 OIL-IN-WATER TYPE COMPOSITION Shiseido Company, Ltd. (JP) 2023-08-30 EP disclosed
US-11730684-B2 Cleansing composition SHISEIDO COMPANY, LTD. (JP) 2023-08-22 US disclosed
EP-4201393-A1 COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN Shiseido Company, Ltd. (JP) 2023-06-28 EP disclosed
US-20230190590-A1 LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION, AND COMPOSITION FOR EXTERNAL-USE SKIN PREPARATION SHISEIDO COMPANY, LTD. (JP) 2023-06-22 US disclosed
US-20230142992-A1 THICKENER FOR NON-AQUEOUS COMPOSITIONS SHISEIDO COMPANY, LTD. (JP) 2023-05-11 US disclosed
US-20110070173-A1 Oil-in-Water Type Emulsion Cosmetic Composition SHISEIDO CO., LTD. (JP) 2011-03-24 US disclosed
US-20100190864-A1 Alkylene Oxide Derivative And Skin External Preparation Containing The Same SHISEIDO COMPANY LTD. (JP) 2010-07-29 US disclosed
EP-2174972-A1 ALKYLENE OXIDE DERIVATIVE AND SKIN EXTERNAL PREPARATION CONTAINING THE SAME Shiseido Company, Ltd. (JP) 2010-04-14 EP disclosed
US-20100075882-A1 External Skin Preparation And Skin Cleanser SHISEIDO COMPANY LTD. (JP) 2010-03-25 US disclosed
US-20090197948-A1 Skin External Preparation SHISEIDO CO., LTD. (JP) 2009-08-06 US disclosed
EP-2027849-A1 EXTERNAL PREPARATION FOR SKIN Shiseido Company, Limited (JP) 2009-02-25 EP disclosed
US-20060110414-A1 Oily skin preparation for external use SHISEIDO CO., LTD. (JP) 2006-05-25 US disclosed
EP-1576947-A1 OILY SKIN PREPARATION FOR EXTERNAL USE Shiseido Co., Ltd. (JP) 2005-09-21 EP disclosed
EP-1576943-A1 COSMETIC OIL-IN-WATER EMULSION PREPARATION Shiseido Co., Ltd. (JP) 2005-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190299032-A1 Oil-In-Water Type Emulsion Cosmetic Composition CD44, DSG1, CUTA CA2 2323/4885MAPK1 4377/4885CA1 1970/4885
US-11730684-B2 Cleansing composition DEGS1, SGMS2, SGMS1 CA2 1017/4885MAPK1 3526/4885CA1 2532/4885
US-20090197948-A1 Skin External Preparation CUTA, OXER1, AKR1B10 CA2 2946/4885MAPK1 2890/4885CA1 3241/4885
US-20100190864-A1 Alkylene Oxide Derivative And Skin External Preparation Containing The Same CUTA, OXER1, OR51E2 CA2 2944/4885MAPK1 2634/4885CA1 4557/4885
US-20230142992-A1 THICKENER FOR NON-AQUEOUS COMPOSITIONS DSG1, AQP1, STOM CA2 3650/4885MAPK1 1903/4885CA1 1928/4885
US-20100075882-A1 External Skin Preparation And Skin Cleanser CUTA, AOC2, AKR1B10 CA2 3132/4885MAPK1 2355/4885CA1 3949/4885
US-20230190590-A1 LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION, AND COMPOSITION FOR EXTERNAL-USE SKIN PREPARATION CUTA, EBP, LIPA CA2 4722/4885MAPK1 4384/4885CA1 4725/4885
US-20060110414-A1 Oily skin preparation for external use CUTA, CETP, LIPA CA2 3402/4885MAPK1 4765/4885CA1 3998/4885
US-20110070173-A1 Oil-in-Water Type Emulsion Cosmetic Composition DSG1, CD44, SQLE CA2 2189/4885MAPK1 4439/4885CA1 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.